Autolus Therapeutics announces publication in Nature Communications
February 22, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics announces publication in Nature Communications
AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic
October 27, 2023 07:00 ET
|
AC Immune SA
PRESS RELEASE AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic ACI-125891 delivers the...
Results of Research on Identification of Covid-19 Viruses Utilizing Advantest's nanoSCOUTER™ Fine Particle Measurement Instrument Published in Nature Communications
June 30, 2021 03:05 ET
|
Advantest America, Inc.
TOKYO, June 30, 2021 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) has announced that the results of a clinical study on the identification of...
Study Published in Nature Shows F-Star’s STING Agonist SB 11285 Enhances Preclinical Efficacy of Radiation Therapy
April 19, 2021 09:27 ET
|
F-star Therapeutics, Inc.
SB 11285 in Combination with Radiation is More Effective than Either as Monotherapy in a Murine Tumor Model SB 11285 is a Second Generation STING Agonist Delivered Intravenously CAMBRIDGE, United...
UPDATE - D-Wave Demonstrates Performance Advantage in Quantum Simulation of Exotic Magnetism
February 18, 2021 12:04 ET
|
D-Wave Systems Inc.
BURNABY, British Columbia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- D-Wave Systems Inc., the leader in quantum computing systems, software, and services, today published a milestone study in collaboration...
D-Wave Demonstrates Performance Advantage in Quantum Simulation of Exotic Magnetism
February 18, 2021 05:00 ET
|
D-Wave Systems Inc.
BURNABY, British Columbia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- D-Wave Systems Inc., the leader in quantum computing systems, software, and services, today published a milestone study in collaboration...